Related Research Articles
Trimethoprim (TMP) is an antibiotic used mainly in the treatment of bladder infections. Other uses include for middle ear infections and travelers' diarrhea. With sulfamethoxazole or dapsone it may be used for Pneumocystis pneumonia in people with HIV/AIDS. It is taken by mouth.
The National Eye Institute (NEI) is part of the U.S. National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services. The mission of NEI is “to eliminate vision loss and improve quality of life through vision research.” NEI consists of two major branches for research: an extramural branch that funds studies outside NIH and an intramural branch that funds research on the NIH campus in Bethesda, Maryland. Most of the NEI budget funds extramural research.
Diabetic nephropathy, also known as diabetic kidney disease, is the chronic loss of kidney function occurring in those with diabetes mellitus. Diabetic nephropathy is the leading causes of chronic kidney disease (CKD) and end-stage renal disease (ESRD) globally. The triad of protein leaking into the urine, rising blood pressure with hypertension and then falling renal function is common to many forms of CKD. Protein loss in the urine due to damage of the glomeruli may become massive, and cause a low serum albumin with resulting generalized body swelling (edema) so called nephrotic syndrome. Likewise, the estimated glomerular filtration rate (eGFR) may progressively fall from a normal of over 90 ml/min/1.73m2 to less than 15, at which point the patient is said to have end-stage renal disease. It usually is slowly progressive over years.
Sulfinpyrazone is a uricosuric medication used to treat gout. It also sometimes is used to reduce platelet aggregation by inhibiting degranulation of platelets which reduces the release of ADP and thromboxane.
Betrixaban is an oral anticoagulant drug which acts as a direct factor Xa inhibitor. Betrixaban is FDA approved for venous thrombosis prevention in adults hospitalized for an acute illness who are at risk for thromboembolic complications. Compared to other directly acting oral anticoagulants betrixaban has relatively low renal excretion and is not metabolized by CYP3A4.
The National Lung Screening Trial was a United States-based clinical trial which recruited research participants between 2002 and 2004. It was sponsored by the National Cancer Institute and conducted by the American College of Radiology Imaging Network and the Lung Screening Study Group. The major objective of the trial was to compare the efficacy of low-dose helical computed tomography and standard chest X-ray as methods of lung cancer screening. The primary study ended in 2010, and the initial findings were published in November 2010, with the main results published in 2011 in the New England Journal of Medicine.
Peter R. Kowey is an American cardiologist and medical researcher. He is Professor of Medicine and Clinical Pharmacology at Jefferson Medical College of Thomas Jefferson University and holds the William Wikoff Smith Chair in Cardiovascular Research at Lankenau Institute for Medical Research.
The Undiagnosed Diseases Network (UDN) is a research study that is funded by the National Institutes of Health Common Fund. Its purpose is to bring together clinical and research experts from across the United States to solve the most challenging medical mysteries using advanced technologies.
The YODA Project is a Yale University project to promote open data in clinical research.
David G. Maloney is an oncologist and researcher at Fred Hutchinson Cancer Research Center and the University of Washington who specializes in developing targeted immunotherapies for the treatment of blood cancers.
Neil R. Powe is an American professor of medicine at the University of California, San Francisco and the chief of medicine at the Zuckerberg San Francisco General Hospital and Trauma Center. Previously he was professor of medicine at the Johns Hopkins University School of Medicine. His research has mainly related to kidney disease, cardiovascular disease and health disparities.
Michele Barry is a professor of medicine. She became Stanford's inaugural Senior Associate Dean of global health in 2009 and started the Stanford Center for Innovation in Global Health in 2010. Prior to this, she was a professor at Yale, where she started the first refugee health clinic and homeless health mobile van project, for which she was awarded the Elm Ivy Mayor’s Award. She specializes in tropical medicine, emerging infectious diseases, women’s leadership in global health, and human and planetary health.
Mads Melbye is director of the Cancer Institute in Denmark (DCRC). He earned his M.D. degree from University of Aarhus, Denmark, in 1983, and a DMSc degree from the same university in 1988. His thesis work was partly done as a fellow in the epidemiology program 1985-1986 at the National Cancer Institute, NIH, US. After clinical training he became senior investigator in 1989 at the Danish Cancer Registry in Copenhagen, and in 1991 state epidemiologist at Statens Serum Institut (SSI) in Copenhagen. In 1992, Melbye was given a personal chair in infectious disease and cancer epidemiology by the Danish minister for research and education. He founded the Department of Epidemiology Research at SSI and to day this department is one of Europe's largest epidemiology research milieus. From 1998 to 2008 he was foreign adjunct professor at Medical Epidemiology and Biostatistics Branch at Karolinska University in Stockholm. In 2012 he established the Danish National Biobank which is one of the biggest biobanks in the world today. Same year he became senior vice-president at Statens Serum Institut in Copenhagen and from 2016 till 2020 president and CEO. He is presently professor of medical epidemiology at University of Copenhagen and affiliated with Department of Genetics at Stanford University School of Medicine.
Shabir Ahmed Madhi is a South African physician who is professor of vaccinology and director of the South African Medical Research Council Respiratory and Meningeal Pathogens Research Unit at the University of the Witwatersrand, and National Research Foundation/Department of Science and Technology Research Chair in Vaccine Preventable Diseases. In January 2021, he was appointed Dean of the Faculty of Health Sciences at the University of the Witwateratand.
Kathy Lynn Hudson is an American microbiologist specializing in science policy. She was the deputy director for science, outreach, and policy at the National Institutes of Health from October 2010 to January 2017. Hudson assisted in the creation and launch of All of Us, the BRAIN initiative, and the National Center for Advancing Translational Sciences. She founded the Genetics and Public Policy Center at Johns Hopkins University in 2002. Hudson is an advocate for women in science.
Monica Bertagnolli is an American surgical oncologist and the 16th director of the National Cancer Institute. Previously, she worked at Brigham and Women's Hospital and Dana–Farber Cancer Institute and was the Richard E. Wilson Professor of Surgery at Harvard Medical School. She has advocated for inclusion of rural communities in clinical studies and served as Chair of the Alliance for Clinical Trials in Oncology until her appointment to lead NCI. Bertagnolli specializes in the treatment of tumors from gastrointestinal diseases and soft tissue sarcomas. She is the former President of the American Society of Clinical Oncology and was elected Fellow of the National Academy of Medicine in 2021.
Jessica Wilen Berg is an American attorney and specialist in Public Health (MPH), currently serving as co-Dean at Case Western Reserve University School of Law, the first female co-Dean or Dean in the law school's 129-year history. She is also Tom J.E. and Bette Lou Walker Professor of Law,Professor in the Departments of Bioethics, and of Population and Quantitative Health Sciences at the CWRU School of Medicine. She is a reference book author in the area of informed consent. Her scholarly opinion is often reported by institutions and media on ethical aspects iof innovative biomedical procedures.
John R. Mascola is an American physician-scientist, immunologist and infectious disease specialist. He was the director of the Vaccine Research Center (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). He also served as a principal advisor to Anthony Fauci, director of NIAID, on vaccines and biomedical research affairs.
Nancy Keating is an American physician who works at the Brigham and Women's Hospital and is a professor at Harvard Medical School. Her research considers the factors that influence quality care for people suffering from cancer.
John D. Puskas is an American researcher, author, inventor and cardiovascular surgeon. As of 2022, he is Professor, Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, and Chairman, Department of Cardiovascular Surgery at Mount Sinai Morningside, Mount Sinai Beth Israel and Mount Sinai West. He holds 11 U.S. patents and co-founded the International Coronary Congress and the International Society for Coronary Artery Surgery. He is credited by ResearchGate with 330 publications and 15,234 citations and as of 2022 Scopus reports an h-index of 62. Puskas is known for advancing coronary artery bypass (CABG) surgery by refining surgical techniques for all-arterial, off-pump CABG and inventing finer instruments to be used for advanced coronary bypass surgical procedures. He is credited with performing the first totally thoracoscopic bilateral pulmonary vein isolation procedure. He is the co-editor of State of the Art Surgical Coronary Revascularization, the first textbook solely devoted to coronary artery surgery.
References
- ↑ "Deborah A. Zarin". The Multi-Regional Clinical Trials Center of Harvard and Brigham and Women's Hospital. Retrieved 3 January 2021.
- ↑ CHP/PCOR News (February 25, 2009). "Deborah Zarin, Director of ClinicalTrials.gov, addresses CHP/PCOR community". fsi-old.stanford.edu. Archived from the original on 18 May 2015. Retrieved 12 May 2015.
- ↑ Belluz, Julia (December 6, 2014). "Why it's about to get a lot harder to hide the results of medical studies". Vox . Retrieved 12 May 2015.
- ↑ staff (April 28, 2014). "Arnold Foundation Awards $6 Million to Boost Quality of Research". philanthropynewsdigest.org. Foundation Center . Retrieved 12 May 2015.
